These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pseudocholinesterase levels and rates of chloroprocaine hydrolysis in patients receiving adequate doses of phospholine iodide. Lanks KW; Sklar GS Anesthesiology; 1980 May; 52(5):434-5. PubMed ID: 7377577 [No Abstract] [Full Text] [Related]
25. Serum pseudocholinesterase in state anxiety. Modai I; Mendelsohn E; Schwartz B J Clin Psychiatry; 1987 May; 48(5):204-6. PubMed ID: 3571175 [TBL] [Abstract][Full Text] [Related]
26. [Effect of short-term treatment with chlorophenoxyisobutyrate on serum lipids and pseudocholinesterase and plasmatic fibrinogen in hyperlipemic patients]. Hărăguş S; Uza G; Opincaru A; Cucuianu M Stud Cercet Med Interna; 1973; 14(1):33-9. PubMed ID: 4806444 [No Abstract] [Full Text] [Related]
27. Susceptibility to leprosy and serum atypical pseudocholinesterase. Thomas M; Job CK; Kurian PV Int J Lepr Other Mycobact Dis; 1976; 44(3):315-8. PubMed ID: 987994 [TBL] [Abstract][Full Text] [Related]
28. Unusual aspects of low levels of pseudocholinesterase in a pregnant patient. Ravindran RS; Cummins DF; Pantazis KL; Strausburg BJ; Baenziger JC Anesth Analg; 1982 Nov; 61(11):953-5. PubMed ID: 6814300 [No Abstract] [Full Text] [Related]
29. Effect of tobramycin on serum pseudocholinesterase levels. Paradelis AG; Balamoutsos NG; Anastassiadou G; Veggou H Methods Find Exp Clin Pharmacol; 1982; 4(2):121-3. PubMed ID: 7121122 [TBL] [Abstract][Full Text] [Related]
30. Pseudocholinesterase deficiency: an additional preoperative consideration in outpatient diagnostic procedures. Putnam LP South Med J; 1977 Jul; 70(7):831-2. PubMed ID: 877646 [TBL] [Abstract][Full Text] [Related]
33. Pseudocholinesterase in patients with coronary artery disease with cardiac arrhythmias. Sainani GS; Gangurde AP; Diwate UP; Shinde SN Indian Heart J; 1979; 31(2):78-83. PubMed ID: 478575 [No Abstract] [Full Text] [Related]
34. [Evaluation of the pseudocholinesterase activity in hyperlipoproteinemia type II and type IV]. Averna MR; Montalto G; Rini GB; Di Fede G; Labisi M; Marino G; Notarbartolo A Boll Soc Ital Biol Sper; 1983 Apr; 59(4):520-4. PubMed ID: 6882547 [TBL] [Abstract][Full Text] [Related]
35. Serum pseudocholinesterase variants in Mexican-born patients with lepromatous leprosy. Rea TH; Ng WG Int J Lepr Other Mycobact Dis; 1978; 46(3-4):333-6. PubMed ID: 569647 [TBL] [Abstract][Full Text] [Related]
36. Serum electrophoretic lipoprotein factors and pseudocholinesterase activity in thyroid disease. Vlaicu R; Popescu E; Popescu TA; Cucuianu M Endocrinologie; 1978; 16(2):147-51. PubMed ID: 209530 [TBL] [Abstract][Full Text] [Related]
38. Pseudocholinesterase activity of human whole blood, bank blood, and blood protein solutions. Schuh FT Anaesthesist; 1975 Mar; 24(3):103-6. PubMed ID: 1147198 [TBL] [Abstract][Full Text] [Related]
39. True and pseudo cholinesterases in depression. Mathew RJ; Ho BT; Khan MM; Perales C; Weinman ML; Claghorn JL Am J Psychiatry; 1982 Jan; 139(1):125-7. PubMed ID: 7055257 [No Abstract] [Full Text] [Related]
40. [The effect of the serum pseudocholinesterase level in oncological patients on the duration of action of Lysthenon]. Kaveshnikov AI Eksp Khir Anesteziol; 1966; 11(4):94-5. PubMed ID: 5989371 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]